Vicarious Surgical (RBOT) Change in Accured Expenses (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Change in Accured Expenses of -$2.2 million for Q3 2025, down 778.06% year-over-year from $319000.0 in Q3 2024, and up 13.55% quarter-over-quarter from -$2.5 million in Q2 2025.
Vicarious Surgical (RBOT) Change in Accured Expenses (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Change in Accured Expenses for 6 consecutive years, with -$2.2 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Change in Accured Expenses fell 778.06% year-over-year to -$2.2 million; the TTM figure through Sep 2025 stood at -$4.1 million (down 1530.16% YoY), while the FY2024 annual figure was $309000.0, up 137.09% from the prior year.
- Change in Accured Expenses rose to -$2.2 million in Q3 2025 per RBOT's latest filing, from -$2.5 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.8 million in Q4 2021 and bottomed at -$2.5 million in Q2 2025.
- Historically, Change in Accured Expenses has averaged $27000.0 across 5 years, with a median of $287000.0 in 2025.
- On a YoY basis, Change in Accured Expenses climbed as much as 10227.55% in 2021 and fell as far as 5779.1% in 2021.
- Vicarious Surgical's Change in Accured Expenses stood at $2.8 million in 2021, then plunged by 84.42% to $443000.0 in 2022, then slumped by 165.69% to -$291000.0 in 2023, then soared by 192.78% to $270000.0 in 2024, then slumped by 901.11% to -$2.2 million in 2025.
- Business Quant data shows RBOT's Change in Accured Expenses at -$2.2 million in Q3 2025, -$2.5 million in Q2 2025, and $287000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.16 Mn |
| Sep 30, 2025 | -2.16 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Mar 31, 2025 | 287,000.00 |
| Mar 31, 2025 | 287,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 1.98 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Dec 31, 2023 | -291,000.00 |
| Dec 31, 2023 | -291,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Jun 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.11 Mn |